Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.94% | 27.04% | 25.73% | 22.91% | 18.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.94% | 27.04% | 25.73% | 22.91% | 18.37% |
| Cost of Revenue | -0.56% | 19.82% | 17.82% | -9.00% | -6.63% |
| Gross Profit | 9.08% | 30.54% | 29.61% | 47.21% | 35.95% |
| SG&A Expenses | -5.49% | 22.67% | 20.58% | 18.50% | 26.76% |
| Depreciation & Amortization | -2.08% | 2.51% | -1.85% | -0.77% | 1.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.58% | 19.61% | 17.44% | 4.01% | 8.71% |
| Operating Income | 51.36% | 64.84% | 60.99% | 238.07% | 105.41% |
| Income Before Tax | 0.87% | 51.52% | 586.07% | 152.48% | 295.48% |
| Income Tax Expenses | 360.67% | 16.19% | 1,658.16% | 381.68% | -192.74% |
| Earnings from Continuing Operations | -25.28% | 64.72% | 430.44% | 129.50% | 538.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.28% | 64.72% | 430.44% | 129.50% | 538.68% |
| EBIT | 51.36% | 64.84% | 60.99% | 238.07% | 105.41% |
| EBITDA | 32.65% | 41.44% | 40.64% | 105.68% | 57.75% |
| EPS Basic | -25.19% | 66.42% | 439.45% | 131.42% | 538.70% |
| Normalized Basic EPS | 55.46% | 61.33% | 125.20% | 194.49% | 114.76% |
| EPS Diluted | -26.17% | 66.67% | 436.89% | 131.58% | 547.83% |
| Normalized Diluted EPS | 54.26% | 61.51% | 126.50% | 197.77% | 115.57% |
| Average Basic Shares Outstanding | -0.11% | -1.02% | -1.70% | -0.82% | 0.01% |
| Average Diluted Shares Outstanding | 0.65% | -1.13% | -2.25% | -1.93% | -0.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |